Journal article
Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study
Authors
Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Lu JD; Rankin BD; Prajapati VH; Vender R; Yeung J
Journal
JAAD International, Vol. 6, , pp. 3–5
Publisher
Elsevier
Publication Date
March 1, 2022
DOI
10.1016/j.jdin.2021.09.007
ISSN
2666-3287